Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Correction

This article was originally published in The Gray Sheet

Executive Summary

"The Gray Sheet" incorrectly reported in the June 28, 2010, issue that David Buckles, who has become acting ombudsman in the Center for Devices and Radiological Health, will occupy the spot vacated by Casper Uldriks. Buckles will in fact be filling the spot vacated by longtime ombudsman Les Weinstein (1"The Gray Sheet" April 12, 2010). Uldriks' former position as associate director for clinical research & government affairs within the Office of the Center Director is still vacant

You may also be interested in...



People In Brief

CDRH needs new ombudsman: Les Weinstein served his last day as ombudsman for FDA's device center April 9 and now moves to the same post within FDA's new Center for Tobacco Products. Weinstein was appointed as CDRH's first ombudsman in 2000 to handle complaints from outside the agency and disputes between the center and companies. CDRH has yet to name a replacement (1"The Gray Sheet" March 20, 2000). Weinstein released his final annual report for the device center April 7

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel